Methods and systems for treating restenosis using electroporation

• US 8,603,087 B2
• Filed: 09/28/2007
• Issued: 12/10/2013
• Est. Priority Date: 06/24/2005
• Status: Active Grant

• Current Assignee: AngioDynamics, Inc.
• Original Assignee: AngioDynamics, Inc.
• Inventors: Rubinsky, Boris, Onik, Gary, Mikus, Paul
• Primary Examiner(s): Peffley, Michael
• Assistant Examiner(s): FOWLER, DANIEL WAYNE
• Application Number:
  US11/864,320
• Publication Number:
  US 20080021371A1
• Time in Patent Office: 2,265 Days
• Field of Search: 606 32- 34, 604 20- 22, 435/173.1
• US Class Current: 606/41
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 2017/22002 preventing restenosis
• CPC Class Codes: A61B 2018/00214 Expandable means emitting energy, e.g. by elements carried thereon
• CPC Class Codes: A61B 2018/0022 Balloons
• CPC Class Codes: A61B 2018/00422 Angioplasty
• CPC Class Codes: A61B 2018/00613 Irreversible electroporation

Abstract

A system is provided for reducing restenosis. A catheter apparatus is provided with at least first and second mono-polar electrodes positioned at an inflatable balloon. The balloon is sized to be positioned and expanded at a restenosis site. A voltage pulse generator is coupled to the first and second mono-polar electrodes. The voltage pulse generator is configured to apply an electric field, in a controlled manner, to the restenosis site in an amount sufficient to produce electroporation of the restenosis site, and below an amount that causes thermal damage to the restenosis site.

Claims

1. A method for reducing restenosis by irreversible electroporation, comprising:

introducing a balloon with a plurality of electrodes through vasculature to a restenosis site;

positioning the balloon at or near the restenosis site;

delivering a test voltage to cells in the restenosis site prior to applying a programmed electric field to the restenosis site

using a programmed control circuit, applying a programmed electric field to the restenosis site among the electrodes through a switching device to activate the electrodes in a selected pattern among a plurality of switching patterns in an amount which is sufficient to induce irreversible electroporation of the restenosis site, but which is insufficient to induce thermal damage to the restenosis site such that the cells in the restenosis site are ablated by irreversible electroporation.

2. The method of claim 1, wherein the test voltage is insufficient to create irreversible electroporation, further comprising determining the adequacy for irreversible tissue electroporation of the restenosis site based on the delivered test voltage.

3. The method of claim 1, wherein the electrodes are at least partially circumferentially positioned around the balloon.

4. The method of claim 1, wherein a predetermined number of longitudinally spaced electrodes are provided to create electroporation along a length of the restenosis site.

5. The method of claim 1, further comprising:

performing the electroporation in a controlled manner with real time monitoring.

6. The method of claim 1, further comprising:

performing the electroporation in a controlled manner to provide for controlled pore formation in cell membranes.

7. The method of claim 1, further comprising:

performing the electroporation in a controlled manner with monitoring of electrical impedance.

8. The method of claim 1, further comprising:

detecting an onset of electroporation of cells at the restenosis site.

9. The method of claim 1, further comprising:

performing the electroporation in a controlled manner with controlled intensity and duration of each pulse in the electric field.

10. The method of claim 1, further comprising:

performing the electroporation in a controlled manner with real time control.

11. The method of claim 1, further comprising:

performing the electroporation in a controlled manner with a proper selection of voltage magnitude.

12. The method of claim 1, wherein the electroporation is performed in a controlled manner with a proper selection of voltage application time.

13. The method of claim 1, wherein the duration of each pulse of the electric field is about 5 microseconds to about 62 seconds.

14. The method of claim 1, wherein the duration of each pulse of the electric field is about 90 to 110 microseconds.

15. The method of claim 1, wherein the duration of each pulse of the electric field is about 100 microseconds.

16. The method of claim 14, wherein about 1 to 15 pulses are applied.

17. The method of claim 14, wherein about eight pulses of about 100 microseconds each in duration are applied.

18. The method of claim 1, wherein pulses are applied to produce a voltage gradient at the restenosis tissue site in a range of from about 50 volt/cm to about 8000 volt/cm.

19. The method of claim 1, further comprising:

monitoring a temperature of the restenosis tissue site; and

adjusting pulses of the electric field to maintain a temperature of 100 degrees C. or less at the restenosis tissue site.

20. The method of claim 1, further comprising:

monitoring a temperature of the restenosis tissue site; and

adjusting pulses of the electric field to maintain a temperature of 75 degrees C. or less at the restenosis tissue site.

21. The method of claim 1, further comprising:

monitoring a temperature of the restenosis tissue site; and

adjusting pulses of the electric field to maintain a temperature of 60 degrees C. or less at the restenosis tissue site.

22. The method of claim 1, further comprising:

monitoring a temperature of the restenosis tissue site; and

adjusting pulses of the electric field to maintain a temperature of 50 degrees C. or less at the restenosis tissue site.

23. The method of claim 1, further comprising:

adjusting a current-to-voltage ratio based on temperature to maintain the restenosis tissue site temperature at 100 degrees C. or less.

24. The method of claim 1, further comprising:

adjusting a current-to-voltage ratio based on temperature to maintain the restenosis tissue site temperature at 75 degrees C. or less.

25. The method of claim 1, further comprising:

adjusting a current-to-voltage ratio based on temperature to maintain the restenosis tissue site temperature at 60 degrees C. or less.

26. The method of claim 1, further comprising:

adjusting a current-to-voltage ratio based on temperature to maintain the restenosis tissue site temperature at 50 degrees C. or less.

27. The method of claim 1, wherein at least one electrical parameter at the restenosis tissue site is detected and a magnitude of applied voltage to the restenosis tissue site is adjusted in accordance with changes in the electrical parameter.

28. The method of claim 1, prior to the step of applying, further comprising imaging the positioned balloon to confirm proper placement of the electrodes.

29. The method of claim 1, further comprising imaging tissue in the restenosis site to determine the effectiveness of the electroporation in real time.

30. A method for reducing restenosis by electroporation, comprising:

introducing a balloon with a plurality of electrodes through vasculature to a restenosis site;

positioning the balloon and the electrodes at or near the restenosis site;

receiving through a user interface a selection of a desired switching pattern among a plurality of switching patterns from a user;

delivering a test voltage to cells in the restenosis site;

after delivering the test voltage, using a programmed control circuit, applying a programmed plurality of electrical pulses to the restenosis site among the electrodes through a switching device to activate the electrodes in the user-selected pattern in an amount which is sufficient to induce electroporation of the restenosis site.

31. The method of claim 30, wherein the step of receiving includes receiving the user selection through a computer mouse or touch screen.

32. The method of claim 30, further comprising positioning a monitoring electrode near a critical location.

33. The method of claim 30, further comprising positioning a monitoring electrode near the restenosis site.

34. The method of claim 30, further comprising:

during the step of applying a programmed plurality of electrical pulses to the restenosis site, monitoring the effects of electroporation on cell membranes at the restenosis site.

35. The method of claim 34, wherein the the step of monitoring includes measuring the current.

36. The method of claim 30, further comprising:

monitoring a temperature of the restenosis tissue site; and

adjusting the electrical pulses to maintain a temperature of 50 degrees C. or less at the restenosis tissue site.

37. The method of claim 30, prior to the step of applying, further comprising imaging the positioned balloon to confirm proper placement of the electrodes.

38. The method of claim 30, further comprising imaging tissue in the restenosis site to determine the effectiveness of the electroporation in real time.